Corbus Pharmaceuticals Holdings, Inc.
Symbol: CRBP (NASDAQ)
14.89
▲ (14.48%) 1.884
Company Description:
Corbus Pharmaceuticals Holdings Inc is a precision oncology company with a diversified portfolio and is committed to helping people defeat serious illness by bringing scientific approaches to well-understood biological pathways. The company's development pipeline includes; CRB-701, a next-generation antibody-drug conjugate (ADC) that targets the expression of Nectin-4 on cancer cells to release a cytotoxic payload, CRB-601, an anti-integrin monoclonal antibody that blocks the activation of TGF expressed on cancer cells, and CRB-913 a second-generation peripherally restricted CB1 receptor inverse agonist designed to treat obesity.
Key Stats
- Today's Open: $13.16
- Today's High: $14.894
- Today's Low: $13.05
- Today's Volume: 287.48K
- Yesterday Close: $13.01
- Yesterday High: $13.49
- Yesterday Low: $13
- Yesterday Volume: 216.25K
- Last Min Volume: 0
- Last Min High: $14.894
- Last Min Low: $14.874
- Last Min VWAP: $0
Company Profile
- Name: Corbus Pharmaceuticals Holdings, Inc.
- Website: https://www.corbuspharma.com
- Listed Date: 2014-10-24
- Location: NORWOOD, MA
- Market Status: Active
- CIK Number: 0001595097
- SIC Code: 2834
- SIC description: PHARMACEUTICAL PREPARATIONS
- Market Cap: $159.44M
- Round Lot: 100
- Outstanding Shares: 12.26M
- Asset Type: CS
RECENT FILINGS FOR CRBP
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-09-16 | 8-K | View |
| 2025-08-05 | 10-Q | View |
| 2025-08-05 | 8-K | View |
| 2025-07-29 | SCHEDULE 13G/A | View |
| 2025-07-16 | SCHEDULE 13G/A | View |
| 2025-06-02 | 4 | View |
| 2025-06-02 | 4 | View |
| 2025-06-02 | 4 | View |
| 2025-06-02 | 4 | View |
| 2025-06-02 | 4 | View |
| 2025-06-02 | 4 | View |
| 2025-05-19 | 8-K | View |
| 2025-05-06 | 10-Q | View |
| 2025-05-06 | 8-K | View |
| 2025-04-01 | ARS | View |
| 2025-04-01 | DEFA14A | View |
| 2025-04-01 | DEF 14A | View |
| 2025-03-21 | 8-K | View |
| 2025-03-18 | 3 | View |
| 2025-03-18 | 8-K | View |
Latest News on CRBP